IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas.
作者信息
Appay Romain, Tabouret Emeline, Macagno Nicolas, Touat Mehdi, Carpentier Catherine, Colin Carole, Ducray François, Idbaih Ahmed, Mokhtari Karima, Uro-Coste Emmanuelle, Dehais Caroline, Figarella-Branger Dominique
机构信息
APHM, Hôpital de la Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.
出版信息
Neuro Oncol. 2018 Apr 9;20(5):716-718. doi: 10.1093/neuonc/noy014.
Abstract
摘要
相似文献
1
IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas.异柠檬酸脱氢酶2（IDH2）突变通常与弥漫性成人胶质瘤中的1p/19q共缺失相关。
Neuro Oncol. 2018 Apr 9;20(5):716-718. doi: 10.1093/neuonc/noy014.
2
Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas.H3K27三甲基化缺失与弥漫性胶质瘤中的1p/19q共缺失相关。
Acta Neuropathol. 2019 Aug;138(2):331-334. doi: 10.1007/s00401-019-02025-9. Epub 2019 May 7.
3
A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.核转运相关基因特征与 IDH 突变和 1p/19q 联合缺失可更好地预测胶质瘤患者的预后。
BMC Cancer. 2020 Nov 9;20(1):1072. doi: 10.1186/s12885-020-07552-3.
4
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH.下一代测序 panel 用于 1p/19q 共缺失和 IDH1-IDH2 突变分析，揭示了 FISH 对 1p/19q 共缺失的误诊。
J Mol Diagn. 2021 Sep;23(9):1185-1194. doi: 10.1016/j.jmoldx.2021.06.004. Epub 2021 Jun 26.
5
1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.1p/19q 共缺失状态与 IDH 突变的低级别胶质瘤中独特的肿瘤相关巨噬细胞浸润有关。
Cell Oncol (Dordr). 2021 Feb;44(1):193-204. doi: 10.1007/s13402-020-00561-1. Epub 2020 Sep 11.
6
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas.异柠檬酸脱氢酶（IDH）突变、1p/19q 缺失及磷酸酶和张力蛋白同源物（PTEN）缺失分析可明确临床低级别弥漫性胶质瘤的预后。
Neuro Oncol. 2014 Jul;16(7):914-23. doi: 10.1093/neuonc/not299.
7
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.CDKN2A 纯合缺失是弥漫性恶性 IDH 突变型神经胶质瘤的一个强烈不良预后因素。
Neuro Oncol. 2019 Dec 17;21(12):1519-1528. doi: 10.1093/neuonc/noz124.
8
Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.联合两种生物标志物，即 IDH1/2 突变和 1p/19q 共缺失，将间变性少突胶质细胞瘤分为三组：单中心经验。
J Neurooncol. 2013 Aug;114(1):85-91. doi: 10.1007/s11060-013-1152-0. Epub 2013 May 17.
9
Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors.弥漫性胶质瘤中H3K27me3水平降低：与1p/19q共缺失的关联以及与恶性外周神经鞘瘤中H3K27me3缺失的差异
Brain Tumor Pathol. 2021 Jan;38(1):23-29. doi: 10.1007/s10014-020-00382-y. Epub 2020 Sep 28.
10
Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results.成人弥漫性胶质瘤的分子分类：异柠檬酸脱氢酶1/异柠檬酸脱氢酶2、α地中海贫血/智力低下综合征X连锁基因和1号染色体短臂/19号染色体长臂结果相互矛盾
Hum Pathol. 2017 Nov;69:15-22. doi: 10.1016/j.humpath.2017.05.005. Epub 2017 May 23.
引用本文的文献
1
Clinical and imaging characteristics of supratentorial glioma with IDH2 mutation.伴有 IDH2 突变的幕上脑胶质瘤的临床和影像学特征。
Neuroradiology. 2024 Jun;66(6):973-981. doi: 10.1007/s00234-024-03361-8. Epub 2024 Apr 24.
2
Towards a clinically applicable histomolecular classification of lung adenocarcinomas?迈向临床适用的肺腺癌组织分子分类？
Transl Lung Cancer Res. 2023 May 31;12(5):953-956. doi: 10.21037/tlcr-23-68. Epub 2023 Apr 7.
3
Imaging 2-hydroxyglutarate and other brain oncometabolites pertinent to critical genomic alterations in brain tumors.成像2-羟基戊二酸及其他与脑肿瘤关键基因组改变相关的脑肿瘤代谢物。
BJR Open. 2023 Mar 22;5(1):20210070. doi: 10.1259/bjro.20210070. eCollection 2023.
4
In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of -Mutant Diffuse Gliomas: The Prospective Study.体内 2-羟基戊二酸监测的编辑磁共振波谱用于 -突变型弥漫性神经胶质瘤的随访：前瞻性研究。
Neurology. 2023 Jan 3;100(1):e94-e106. doi: 10.1212/WNL.0000000000201137. Epub 2022 Sep 30.
5
H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology.H3K27me3 免疫染色在具有少突胶质或混合少突星形细胞瘤形态的弥漫性神经胶质瘤中具有诊断和预后价值。
Virchows Arch. 2021 Nov;479(5):987-996. doi: 10.1007/s00428-021-03134-1. Epub 2021 Jun 24.
6
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment.IDH 抑制剂及其他：靶向胶质瘤治疗的基石。
Mol Diagn Ther. 2021 Jul;25(4):457-473. doi: 10.1007/s40291-021-00537-3. Epub 2021 Jun 7.
7
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.伴有非典型 IDH 突变的 IDH 突变型胶质瘤的特征。
J Neurooncol. 2021 Jan;151(2):279-286. doi: 10.1007/s11060-020-03662-x. Epub 2020 Nov 17.
8
Clinical Management of Diffuse Low-Grade Gliomas.弥漫性低级别胶质瘤的临床管理
Cancers (Basel). 2020 Oct 16;12(10):3008. doi: 10.3390/cancers12103008.
9
Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of "dual-genotype" IDH-mutant infiltrating gliomas.“双基因型”异柠檬酸脱氢酶（IDH）突变型浸润性胶质瘤单个克隆内伴发的1p/19q共缺失以及IDH1/2、ATRX和TP53突变
Acta Neuropathol. 2020 Jun;139(6):1105-1107. doi: 10.1007/s00401-020-02141-x. Epub 2020 Mar 13.
10
Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas.低级别胶质瘤中异柠檬酸脱氢酶 2 基因突变的临床神经病理学特征。
Chin Med J (Engl). 2019 Dec 20;132(24):2920-2926. doi: 10.1097/CM9.0000000000000565.
本文引用的文献
1
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.2016 年世界卫生组织弥漫性胶质瘤分类对法国 POLA 队列的预后影响。
Acta Neuropathol. 2016 Oct;132(4):625-34. doi: 10.1007/s00401-016-1611-8. Epub 2016 Aug 29.
2
The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas.胶质瘤中IDH1和IDH2突变的临床与生物学特征比较。
J Exp Clin Cancer Res. 2016 May 31;35:86. doi: 10.1186/s13046-016-0362-7.
3
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类：概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
4
The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization.异柠檬酸脱氢酶突变产生 2-羟基戊二酸的潜力取决于等位基因特异性和亚细胞区室化。
J Biol Chem. 2013 Feb 8;288(6):3804-15. doi: 10.1074/jbc.M112.435495. Epub 2012 Dec 21.
5
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.异柠檬酸脱氢酶1（IDH1）突变是星形细胞瘤和少突胶质细胞瘤发生过程中的早期事件。
Am J Pathol. 2009 Apr;174(4):1149-53. doi: 10.2353/ajpath.2009.080958. Epub 2009 Feb 26.
6
IDH1 and IDH2 mutations in gliomas.胶质瘤中的异柠檬酸脱氢酶1（IDH1）和异柠檬酸脱氢酶2（IDH2）突变
N Engl J Med. 2009 Feb 19;360(8):765-73. doi: 10.1056/NEJMoa0808710.
Zotero 插件